When adjusters have to jump through hoops to make referrals, they lose precious time. When it comes to specialty services, we have your back.
More stories
Enlyte
Article
FDA Approves Combination NSAID/Opioid Seglentis
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA).
Mitchell
Virtual Event
Navigating Michigan’s No-Fault Auto Fee Schedule Four Months In
On-Demand
On July 2, 2021, Michigan’s new auto fee schedule went into effect for services rendered on or after that date.
Enlyte
News Release
Enlyte Family of Companies Publish Inaugural Report Offering Trends and Predictions for Property & Casualty (P&C) and Collision Repair Industries
SAN DIEGO—October 19, 2021—Enlyte, the new parent brand unifying Mitchell, Genex and Coventry, today released its inaugural report
Enlyte
News Release
Mitchell, Genex and Coventry Unite Under a Single, New Brand: Meet Enlyte
SAN DIEGO, CA—October 13, 2021—Mitchell, Genex and Coventry formally announced today the creation of their new parent brand, Enlyt
Enlyte
News Release
Mitchell, Genex and Coventry Unite Under a Single, New Brand: Meet Enlyte
As a unified brand, Enlyte aligns the companies’ teams to enable improved client focus, while leveraging the breadth of solutions and expertis
Mitchell
Virtual Event
2021 mPower Virtual Conference
On-Demand
The Mitchell | Genex | Coventry team looks forward to connecting with you at the 2021 mPower Conference, taking place virtually October 12–14, 2021